Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.
Islet transplantation can reduce or eliminate the need for insulin in patients with type 1 diabetes. Exenatide is a long acting analogue of Glucagon-like peptide-1 (GLP-1) that augments glucose induced insulin secretion, and may increase beta cell mass. We evaluated the effect of exenatide on insulin secretion after islet transplantation.
Version: za2963e q8za0 q8zbc q8zc7 q8zde q8ze3 q8zf7 q8zg9